Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.84 |
| ▸ | USP2 | O75604 | 4/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.84 |
| ▸ | HAT1 | O14929 | 4/20 | 0.84 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.84 |
| ▸ | HTT | P42858 | 4/20 | 0.84 |
| ▸ | RECQL | P46063 | 3/20 | 0.84 |
| ▸ | CASP7 | P55210 | 3/20 | 0.84 |
| ▸ | MAPT | P10636 | 3/20 | 0.84 |
| ▸ | CASP1 | P29466 | 2/20 | 0.84 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.84 |
| ▸ | TST | Q16762 | 2/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.84 |
| ▸ | LMNA | P02545 | 1/20 | 0.84 |
| ▸ | HBB | P68871 | 1/20 | 0.84 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin SCHEMBL182060 | 1.00 | MEN1 (0.84) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27497064 | 0.99 | MEN1 (0.82) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL5991517 | 0.95 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL5991520 | 0.95 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL6662783 | 0.95 | MEN1 (0.75) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27781309 | 0.95 | MEN1 (0.81) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27764351 | 0.95 | MEN1 (0.81) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL2800233 | 0.94 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL2800236 | 0.94 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27604024 | 0.93 | MEN1 (0.78) | MEN1KMT2AUSP2KDM4EHAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1653 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12365850-B2 | Water-miscible functional fluid, undiluted stock of water-miscible functional fluid, sterilizer for water-miscible functional fluid, and method of sterilizing water-miscible function fluid | YUSHIRO CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-07-22 | — | — | US | claimed |
| CN-119185313-A | Leishmod prodrug, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-12-27 | — | — | CN | claimed |
| WO-2024225436-A1 | OPHTHALMIC COMPOSITION | 株式会社メドレックス | 2024-10-31 | — | — | WO | claimed |
| WO-2021261599-A1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR NOVEL CORONA VIRUS INFECTIOUS DISEASE | 荒木 誠一 | 2021-12-30 | — | — | WO | claimed |
| CN-108135883-B | Pharmaceutical composition containing arylalkylamine compound | 协和麒麟株式会社 | 2021-09-14 | — | — | CN | claimed |
| US-10350194-B2 | Pharmaceutical composition containing an arylalkylamine compound | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2019-07-16 | — | — | US | claimed |
| US-20180296526-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING AN ARYLALKYLAMINE COMPOUND | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2018-10-18 | — | — | US | claimed |
| CN-108135883-A | Pharmaceutical composition containing arylalkylamine compound | 协和发酵麒麟株式会社 | 2018-06-08 | — | — | CN | claimed |
| EP-2050439-B1 | PROCESS FOR PRODUCTION OF SPHERICAL GRANULE CONTAINING SLIGHTLY WATER-SOLUBLE SUBSTANCE | ASAHI CHEMICAL IND (JP) | 2016-11-23 | — | — | EP | claimed |
| US-20150343009-A1 | ORALLY ADMINISTERED LIQUID FORMULATION | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2015-12-03 | — | — | US | claimed |
| CN-1489462-A | Blood lipid ameliopant composition | 三共株式会社 | 2004-04-14 | — | — | CN | claimed |
| CN-1489464-A | Blood lipid improving agent composition | 三共株式会社 | 2004-04-14 | — | — | CN | claimed |
| US-20040023919-A1 | Blood lipid ameliorant composition | SANKYO COMPANY, LIMITED (JP) | 2004-02-05 | — | — | US | claimed |
| US-20040014712-A1 | Blood lipid ameliorant composition | SANKYO COMPANY, LIMITED (JP) | 2004-01-22 | — | — | US | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| EP-0328129-B1 | Yellow-colored solid matter and production thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1994-08-17 | — | — | EP | claimed |
| EP-0553777-A2 | Fast dissolving tablet and its production | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-08-04 | — | — | EP | claimed |
| EP-0328129-A2 | Yellow-colored solid matter and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1989-08-16 | — | — | EP | claimed |
| US-4612187-A | Oryzanol-containing soft capsule | NISSHIN CHEMICALS CO., LTD. (JP) | 1986-09-16 | — | — | US | claimed |
| US-3962436-A | Pharmaceutical compositions having controlled rate of gastro-intestinal absorption | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-06-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180296526-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING AN ARYLALKYLAMINE COMPOUND | NAT1, ABCB11, ADRA1A | MEN1 2167/4885KMT2A 1428/4885USP2 4584/4885 |
| US-10350194-B2 | Pharmaceutical composition containing an arylalkylamine compound | NAT1, ADRA1A, ADRA1B | MEN1 2197/4885KMT2A 1311/4885USP2 4522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.